Academic literature on the topic 'IL-4'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'IL-4.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "IL-4"
Usha, Prof. "IL-4 and IL-6 in Bronchial Asthma Does IL-6 Plays More Important Role than IL-4? A Preliminary Study." Journal of Medical Science And clinical Research 05, no. 04 (April 18, 2017): 20446–50. http://dx.doi.org/10.18535/jmscr/v5i4.115.
Full textKelly-Welch, A., E. M. Hanson, and A. D. Keegan. "Interleukin-4 (IL-4) Pathway." Science Signaling 2005, no. 293 (July 12, 2005): cm9. http://dx.doi.org/10.1126/stke.2932005cm9.
Full textBorish, Larry. "IL-4 and IL-13 Dual Antagonism." American Journal of Respiratory and Critical Care Medicine 181, no. 8 (April 15, 2010): 769–70. http://dx.doi.org/10.1164/rccm.201002-0147ed.
Full textSchindler, C., H. Kashleva, A. Pernis, R. Pine, and P. Rothman. "STF-IL-4: a novel IL-4-induced signal transducing factor." EMBO Journal 13, no. 6 (March 1994): 1350–56. http://dx.doi.org/10.1002/j.1460-2075.1994.tb06388.x.
Full textGause, W. C., T. Takashi, J. D. Mountz, F. D. Finkelman, and A. D. Steinberg. "Activation of CD 4-, CD 8- thymocytes with IL 4 vs IL 1 + IL 2." Journal of Immunology 141, no. 7 (October 1, 1988): 2240–45. http://dx.doi.org/10.4049/jimmunol.141.7.2240.
Full textNAKANISHI, KENJI. "Interleukin cascade of IL-4,IL-5 and IL-2." Japanese Journal of Clinical Immunology 13, no. 5 (1990): 438–40. http://dx.doi.org/10.2177/jsci.13.438.
Full textAtamas, S. P., J. Choi, V. V. Yurovsky, and B. White. "An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation." Journal of Immunology 156, no. 2 (January 15, 1996): 435–41. http://dx.doi.org/10.4049/jimmunol.156.2.435.
Full textNoben-Trauth, N., L. D. Shultz, F. Brombacher, J. F. Urban, H. Gu, and W. E. Paul. "An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice." Proceedings of the National Academy of Sciences 94, no. 20 (September 30, 1997): 10838–43. http://dx.doi.org/10.1073/pnas.94.20.10838.
Full textHo, S. N., R. T. Abraham, A. Nilson, B. S. Handwerger, and D. J. McKean. "Interleukin 1-mediated activation of interleukin 4 (IL 4)-producing T lymphocytes. Proliferation by IL 4-dependent and IL 4-independent mechanisms." Journal of Immunology 139, no. 5 (September 1, 1987): 1532–40. http://dx.doi.org/10.4049/jimmunol.139.5.1532.
Full textReich, Adam, Justyna Szczęch, and Dominik Samotij. "Biologics for Itch: IL-4/IL-13, IL-31, IL-17, and IL-23 Antagonists." Current Dermatology Reports 6, no. 4 (October 17, 2017): 263–72. http://dx.doi.org/10.1007/s13671-017-0204-7.
Full textDissertations / Theses on the topic "IL-4"
Dawson, Charlotte Helen. "STAT 6 and IL-4 signalling." Thesis, University of Sheffield, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.245716.
Full textNieuwenhuizen, Natalie. "Immune and allergic responses to Anisakis pegreffii, with focus on the roles of IL-4, IL-13 and the IL-4 receptor alpha." Doctoral thesis, University of Cape Town, 2007. http://hdl.handle.net/11427/3115.
Full textThe fish-parasitizing nematode Anisakis pegreffii induces gastrointestinal disease and allergy when ingested by humans, and can cause occupational allergy in seafood processing workers. The present study examines immune and allergic responses to A. pegreffii in wildtype and gene deficient mice, with special focus on interleukin(IL)-4, IL-13, and the IL-4 receptor alpha (IL-4Rα). Experimental murine models of Anisakis infection, Anisakis-induced anaphylaxis and Anisakis-induced dermatitis were established in order to gain insight into the immune responses generated against Anisakis and unravel mechanisms of allergic disease.
Oksuz, Samet. "Targeting IL-4 locus for epigenetic reprogramming." University of Cincinnati / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1423581203.
Full textGovender, Melissa. "Investigating the role of IL-4/IL-13 signalling through the IL-4 receptor alpha (IL-4Rα) on keratinocytes in murine models of Leishmania major and Schistosoma mansoni." Doctoral thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/24890.
Full textМозгова, Юлія Анатоліївна, Юлия Анатольевна Мозговая, and Yuliia Anatoliivna Mozghova. "Динаміка вмісту IL-4 та IL-6 при хронічному тонзиліті в дітей." Thesis, Сумський державний університет, 2013. http://essuir.sumdu.edu.ua/handle/123456789/32359.
Full textPizzuti, Lucas. "Síntese de 4-(fur-2-il)- e 4-(tien-2-il)-pirimidinas a partir de β-Alcoxivinil trifluormetil cetonas." Universidade Federal de Santa Maria, 2005. http://repositorio.ufsm.br/handle/1/10401.
Full textThe cyclocondensation of the 1,1,1-trifluoro-4-methoxy-4-(2-heteroaryl)-3-buten-2-ones (heteroaryl = furyl and thienyl) with urea and amidines (acetamidine, benzamidine, guanidine, 1H-pyrazole-1-carboxamidine and 2-methyl-2-thiopseudourea) for synthesis of two 4-(2-heteroaryl)-6-trifluoromethylpyrimidinones and a series of ten 4-(2-heteroaryl)-6-trifluoromethylpyrimidines is reported. The reaction of the 1,1,1-trifluoro-4-methoxy-4-(2-heteroaryl)-3-buten-2-ones with urea was carried out in the presence of boron trifluoride etherate as a catalyst, at 50°C for 20 hours. The reactions of the same substracts with amidines were carried out in the presence of a 1 M solution of sodium hydroxide at r.t.-50°C for 1 hour. Under this conditions, only aromatic pyrimidines were obtained in 48-67%.
Este trabalho relata a síntese e isolamento de duas 4-(2-heteroaril)-6-trifluormetilpirimidinonas e uma série de dez 4-(2-heteroaril)-6-trifluormetilpirimidinas (heteroaril = furil e tienil), a partir da ciclocondensação de 1,1,1-trifluor-4-metoxi-4-(2-heteroaril)-3-buten-2-onas com uréia e amidinas (acetamidina, benzamidina, guanidina, 1Hpirazolil-1-carboxamidina e 2-metil-2-tiopseudouréia). A reação de 1,1,1-trifluor-4-metoxi-4-(2-heteroaril)-3-buten-2-onas com uréia ocorreu na presença de BF3.Et2O como catalisador, à 50°C por 20 horas. As reações dos mesmos substratos com amidinas ocorreu na presença de uma solução 1 M de NaOH à t.a.-50°C por 1 hora. Nestas condições, foram obtidas somente pirimidinas aromáticas com rendimentos entre 48-67%.
Cirocco, Robert E. "Cytokine analisys in atlantic bottlenose dolphins: molecular characterization of IL-4, IL-6, and IL-10." FIU Digital Commons, 2001. http://digitalcommons.fiu.edu/etd/2370.
Full textVale, Mariana Lima. "Atividade analgesica das interleucinas 4, 10 e 13 (IL-4, IL-10 e il-13) na dor inflamatoria experimental : papel de celulas residentes e citocinas." reponame:Repositório Institucional da UFC, 2000. http://www.repositorio.ufc.br/handle/riufc/2569.
Full textSubmitted by denise santos (denise.santos@ufc.br) on 2012-05-04T12:19:28Z No. of bitstreams: 1 2000_dis_mlvale.pdf: 664941 bytes, checksum: a8df00b6a53f2d6632ebe816657800aa (MD5)
Approved for entry into archive by Eliene Nascimento(elienegvn@hotmail.com) on 2012-05-04T12:36:24Z (GMT) No. of bitstreams: 1 2000_dis_mlvale.pdf: 664941 bytes, checksum: a8df00b6a53f2d6632ebe816657800aa (MD5)
Made available in DSpace on 2012-05-04T12:36:24Z (GMT). No. of bitstreams: 1 2000_dis_mlvale.pdf: 664941 bytes, checksum: a8df00b6a53f2d6632ebe816657800aa (MD5) Previous issue date: 2000
The release of cyclo-oxigenase products and sympathomimetics amines, the final mediators of inflammatory pain, is preceded by the generation of cytokines by resident cells. In recent years a number of cytokines such as IL-4, IL-10, IL-13, IL-6, TGF-β e IFN-α have been described to inhibit the production of TNF-α, IL-1β, IL-6 and IL-8 (cytokines regarded as pró-inflammatory) and possibly to exert their modulatory effect on macrophages and mast cells. Since it is known the capacity of those cytokines to inhibit the production of pro-inflammatory cytokines and the pivotal role of resident cells in the development of inflammatory pain we have decided to test the possibility of IL-4, IL-13 and IL-10 to modulate inflammatory pain. In short, IL-4 (1 – 5ng/animal), IL-13 (0.4 - 2.5ng/animal) or IL-10 (0.4 - 10ng/animal) was given 30 min before acetic acid (AAc) or zymosan (Zym) administration in the writhing model. IL-4 (2.5 e 5 ng/animal), IL-13 (1 e 2.5 ng/animal) or IL-10 (2 e 10 ng/animal) were injected, ip, 30 min before Zym (1 mg/animal; intra-articular) in the rat knee joint incapacitation test up to the 4th hour (the number of leukocytes was determined in the articular exsudate 6 hours later). Doses of those cytokines that exerted maximum effect in the writhing test were also injected 30 min before the hot plate test. These same doses were injected ip before naloxone administration in the AAc-induced writhing model in mice. TNF-α and IL-1β were determined in the supernatant of a macrophage culture which were collected from peritoneal fluid of mice treated with Zym and pre-treated with the cytokines under test. Our results show that interleukins 4, 13 and 10 inhibit writhing response in mice induced by AAc or Zym up to 58.7, 89.2 and 52%, and up to 62.6, 61.7 and 74.4%, respectively (p<0.05). Similar results were observed in the rat knee joint incapacitation test induced by Zym: 49.2, 56.6, 69,9% of inhibition (p<0.05). The same interleukins were able to inhibit Zym-induced leukocyte influx into articular cavity (53.8, 92.1 e 62% of inhibition, respectively - p<0,05). The analgesic activity of IL-4, IL-13 and IL-10 seems to be peripheral, since these cytokines presented no effect in the reaction time of the animals on hot plate test. This antinociceptive effect seems to have no relation with endogen opioid release since naloxone (opioid receptor antagonist) had no effect in reverting the antinociceptive effect of cytokines in the AAc-induced writhing in mice. However, IL-4 and IL-10 inhibit the release of TNF-α (42 e 41.2%, respectively - p<0.05) and of IL-1β (61.9 e 80.9%, respectively - p<0,05) by macrophages stimulated in vivo by Zym, indicating that their antinociceptive activities may be due to the inhibition of those cytokines release by resident cells.
Já está estabelecido que a liberação de produtos da cicloxigenase e aminas simpatomiméticas, mediadores finais da dor inflamatória é precedido pela geração, por células residentes, de uma cascata de citocinas. Recentemente dados do nosso laboratório demonstraram que no modelo de contorções abdominais (CA) a ativação dessa cascata é dependente também da presença de células residentes como macrófagos e mastócitos. Dados da literatura apontam algumas citocinas capazes de modular negativamente a função dessas células: IL-4,. IL-10, IL-13, IL-6, TGF-β e IFN-α . Com base nesses dados, o objetivo do presente trabalho foi estudar uma possível atividade analgésica de três citocinas: IL-4, IL-13 e IL-10. Para tanto injetou-se, via ip, IL-4 (1–5ng/animal), IL-13 (0.4-2.5ng/animal) ou IL-10 (0.4-10ng/animal) 30 min antes da administração de zymosan (Zym) ou ácido acético (AAc) para o teste de CA. IL-4 (2.5 e 5ng/animal), IL-13 (1 e 2.5ng/animal) ou IL-10 (2 e 10ng/animal) foi injetada, ip, 30 min antes do Zym (1 mg/animal; intra-articular) e logo após foi medida a incapacitação articular (IA) até a 4ª hora e na 6ª hora foi feita a contagem de leucócitos no fluido articular. As interleucinas estudadas também foram administradas (30 min antes) na dose que melhor inibiu as CA no teste da placa quente (PQ) e em camundongos que haviam recebido ou não a naloxona previamente ao estímulo (AAc) no teste de CA. IL-4 (5 ng/animal) ou IL-10 (10 ng/animal) foi injetada ip 30 min antes do Zym (ip) e após 15 min os animais foram sacrificados e o exsudato peritoneal foi colhido e posto em cultura para a dosagem de IL-1β e TNF-α no sobrenadante. No presente trabalho ficou demonstrado que as interleucinas-4, 13 e 10 são analgésicas tanto no modelo de CA induzidas por AAc (58.7, 89.2, 52% de inibição, efeito máximo, respectivamente, p<0.05) ou Zym (62.6, 61.7, 74.4% de inibição, efeito máximo, respectivamente, p<0.05) como também no modelo de IA induzido por Zym (49.2, 56.6, 69,9% de inibição, efeito máximo, respectivamente, p<0.05). As citocinas estudadas foram capazes de inibir o influxo de leucócitos para a cavidade articular (53.8, 92.1 e 62%, respectivamente - p<0,05). Foi demonstrado que o efeito analgésico parece ser de domínio periférico visto que nenhuma das citocinas modificou o tempo de reação na PQ, teste algesimétrico sensível apenas para drogas que exercem efeito central. Também foi demonstrado que a atividade analgésica das interleucinas testadas não depende da liberação de opióides endógenos, visto que o pré-tratamento com naloxona não foi capaz de reverter a atividade analgésica de nenhuma das interleucinas no modelo de CA. Contudo essa atividade analgésica parece depender da inibição da liberação de citocinas por células residentes visto que IL-4 e IL-10 foram capazes de diminuir a liberação de TNF-α (42 e 41.2% de inibição respectivamente - p<0.05) e IL-1β (61.9 e 80.9% de inibição respectivamente - p<0,05) por macrófagos peritoneais residentes.
Toor, Iqbal Singh. "Investigating the role of eosinophils in cardiac remodelling following myocardial infarction." Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/31187.
Full textDheda, Keertan Unkha Jairam. "The expression and role of IL-4 and IL-4(delta)2 in tuberculosis with and without HIV co-infection." Thesis, University College London (University of London), 2006. http://discovery.ucl.ac.uk/1445411/.
Full textBooks on the topic "IL-4"
Samolot bombowy DB-3/Ił-4. Warszawa: Dom Wydawniczy Bellona, 2006.
Find full textMutin, U. G. Lichnai︠a︡ voĭna mekhanika Il-4. Staryĭ Oskol: Rosa, 2012.
Find full text1948-, Spits Hergen, ed. IL-4: Structure and function. Boca Raton, FL: CRC Press, 1992.
Find full textKotelnikov, Vladimir. Il-4: "vozdushnye kreĭsera" Stalina. Moskva: I︠A︡uza, 2009.
Find full textLazara, Silvia Ferri de, Giulia D'Amaro Valle, and Enoch Battagin. Cos'è il contemporaneo? 4: What is the contemporary? 4. Padova: CLEUP, 2012.
Find full textTrevisi, Giuseppe. Il delitto Fanin: 4 novembre 1948. Bologna: Il Mulino, 1998.
Find full textIl gastigamatti: Commedia in 4 atti. Firenze: FirenzeLibri, 2010.
Find full textGiuseppe, Verdi. Il trovatore: Dramma in 4 parti. Roma: Gremese Editore, 1988.
Find full textGiuseppe, Verdi. Il Trovatore: Dramma in 4 parti. Roma: Gremese Editore, 1988.
Find full textNatacha, Godeau, ed. Shrek 4: Il était une fin. [Paris]: Hachette jeunesse, 2010.
Find full textBook chapters on the topic "IL-4"
Ranasinghe, Charani, Sreeja Roy, Zheyi Li, Mayank Khanna, and Ronald J. Jackson. "IL-4 and IL-13 Receptors." In Encyclopedia of Signaling Molecules, 2549–57. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_101978.
Full textRanasinghe, Charani, Sreeja Roy, Zheyi Li, Mayank Khanna, and Ronald J. Jackson. "IL-4 and IL-13 Receptors." In Encyclopedia of Signaling Molecules, 1–8. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4614-6438-9_101978-1.
Full textPelaia, Girolamo, Alessandro Vatrella, and Rosario Maselli. "Anti-IL-4/IL-13 Biologics." In Asthma: Targeted Biological Therapies, 67–81. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-46007-9_6.
Full textBorish, Larry, John W. Steinke, Marion Kasaian, and Samuel J. Goldman. "IL-4- and IL-13-directed approaches." In New Drugs and Targets for Asthma and COPD, 115–21. Basel: KARGER, 2010. http://dx.doi.org/10.1159/000320808.
Full textSchroeder, John T. "Diagnostic Components: T Helper Cell Cytokines (IL-4, IL-5, IL-9, IL-10, IL-13, IL-17)." In Encyclopedia of Medical Immunology, 221–26. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-9194-1_298.
Full textKeegan, Achsah, Keats Nelms, and William E. Paul. "The IL-4 Receptor — Signaling Mechanisms." In Advances in Experimental Medicine and Biology, 211–15. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4899-0987-9_21.
Full textClair, R. P. "Saturday, September 4, 2010—Chicago, IL." In Zombie Seed and the Butterfly Blues, 323–25. Rotterdam: SensePublishers, 2013. http://dx.doi.org/10.1007/978-94-6209-308-9_60.
Full textClair, R. P. "Saturday, September 4, 2010—Chicago, IL." In Zombie Seed and the Butterfly Blues, 327. Rotterdam: SensePublishers, 2013. http://dx.doi.org/10.1007/978-94-6209-308-9_61.
Full textShirokaze, J., K. Yanagida, K. Shudo, K. Konomoto, K. Kamiya, and K. Sagara. "IL-4 Production Using Macroporous Microcarrier." In Animal Cell Technology: Developments Towards the 21st Century, 877–81. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0437-1_141.
Full textKhan, Manzoor M. "Regulation of IL-4 and IL-5 Secretion by Histamine and PGE2." In Advances in Experimental Medicine and Biology, 35–42. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1891-4_5.
Full textConference papers on the topic "IL-4"
Kalinauskaitė-Žukauskė, Virginija, Andrius Januškevičius, Ieva Janulaitytė, and Kęstutis Malakauskas. "IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model." In Abstracts from the 17th ERS Lung Science Conference: ‘Mechanisms of Acute Exacerbation of Respiratory Disease’. European Respiratory Society, 2019. http://dx.doi.org/10.1183/23120541.lungscienceconference-2019.pp237.
Full textMuchtar, R. Masri. "294 Polymorphism promotor gene of il-4 and il-4 level at graves disease patients." In LUPUS 2017 & ACA 2017, (12th International Congress on SLE &, 7th Asian Congress on Autoimmunity). Lupus Foundation of America, 2017. http://dx.doi.org/10.1136/lupus-2017-000215.294.
Full textHaque, S. Jaharul, Rikhia Chakraborty, Pankaj Sharma, Suzy Comhair, Sudakshina Ghosh, Weiling Xu, Manoj M. Veleeparambil, et al. "Antioxidant-Mediated Negative Regulation Of IL-4/IL-13 Signaling." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2794.
Full textKalinauskaitė-Žukauskė, Virginija, Andrius Januškevičius, Ieva Janulaitytė, and Kęstutis Malakauskas. "LSC - 2019 - IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4083.
Full textButova, Tatiana, Mykhailo Kuzhko, Dmytro Butov, and Nataliya Piriatinskaa. "Association between IL-2,IL-4 gene polymorphisms and pulmonary MDRTB." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa3035.
Full textYadav, Aravind, Rakesh Naidu, and Gopala Krishnan Govindasamy. "IL-4, IL-13 And IL-4RA Gene Polymorphisms And The Risk For Developing Idiopathic Nonallergic Rhinitis." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4191.
Full textPunia, Navneet, Jennifer Thomson, Irene Babirad, and Roma Sehmi. "IL-4 And IL-13 Prime The Transmigrational Responses Of Hemopoietic Progenitor Cells." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4034.
Full textWirth, F., A. Lubosch, C. Zöller, K. Huck, and I. Nakchbandi. "Osteoblasten stimulieren die Hämatopoese durch IL-4 Produktion." In Jahreskongress DVO OSTEOLOGIE 2021. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0040-1722115.
Full textLe Floc’H, Audrey, Jeanne Allinne, Kirsten Nagashima, George Scott, Dylan Birchard, Seblewongel Asrat, Matthew Sleeman, Andrew Murphy, and Jamie Orengo. "Il-4 and IL-13 act independently and synergistically to drive type 2 inflammation." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa5206.
Full textBlauvelt, Andrew, and Susanne Kammerer. "Novel IL-4/IL-13 blocker shows high efficacy with only modest conjunctivitis signal." In 2022 American Academy of Dermatology Annual Meeting, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/8aee17f2.
Full textReports on the topic "IL-4"
Cao, Xianling, Xuanyou Zhou, Naixin Xu, Songchang Chang, and Chenming Xu. Association of IL-4 and IL-10 Polymorphisms with Preterm Birth Susceptibility: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0044.
Full textGilroy, Jill M. Overexpression of IL-4 Signaling Pathway to Inhibit Breast Tumor Growth. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada403390.
Full textGooch, Jennifer L. Overexpression of IL-4 Signaling Pathway to Inhibit Breast Tumor Growth. Fort Belvoir, VA: Defense Technical Information Center, July 1999. http://dx.doi.org/10.21236/ada390684.
Full textGooch, Jennifer. Overexpression of IL-4 Signaling Pathway to Inhibit Breast Tumor Growth. Fort Belvoir, VA: Defense Technical Information Center, July 2000. http://dx.doi.org/10.21236/ada384372.
Full textSachdev, Deepali. Role of IRS-1 Phosphorylation in IGF-1 and IL-4 Signaling in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2001. http://dx.doi.org/10.21236/ada396609.
Full textSachdev, Deepali. Role of IRS-1 Phosphorylation in IGF-1 and IL-4 Signaling in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2002. http://dx.doi.org/10.21236/ada407504.
Full textSachdev, Deepali. Role of IRS-1 Phosphorylation in IGF-1 and IL-4 Signaling in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2003. http://dx.doi.org/10.21236/ada418308.
Full textLiu, Miao, Hongan Wang, Jing Lu, Zhiyue Zhu, Chaoqun Song, Ye Tian, Xinzhi Chen, et al. Vitamin D supplementation in the treatment of Myasthenia Gravis A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0129.
Full textShomer, Ilan, Louise Wicker, Uzi Merin, and William L. Kerr. Interactions of Cloud Proteins, Pectins and Pectinesterases in Flocculation of Citrus Cloud. United States Department of Agriculture, February 2002. http://dx.doi.org/10.32747/2002.7580669.bard.
Full textElmann, Anat, Orly Lazarov, Joel Kashman, and Rivka Ofir. therapeutic potential of a desert plant and its active compounds for Alzheimer's Disease. United States Department of Agriculture, March 2015. http://dx.doi.org/10.32747/2015.7597913.bard.
Full text